The Role of Regulatory Cell Death in Vitiligo.

RCD melanocyte research progress vitiligo

Journal

DNA and cell biology
ISSN: 1557-7430
Titre abrégé: DNA Cell Biol
Pays: United States
ID NLM: 9004522

Informations de publication

Date de publication:
28 Dec 2023
Historique:
medline: 28 12 2023
pubmed: 28 12 2023
entrez: 28 12 2023
Statut: aheadofprint

Résumé

Vitiligo is one of the common chronic autoimmune skin diseases in clinic, which is characterized by localized or generalized depigmentation and seriously affects the physical and mental health of patients. At present, the pathogenesis of vitiligo is not clear; mainly, heredity, autoimmunity, oxidative stress, melanocyte (MC) self-destruction, and the destruction, death, or dysfunction of MCs caused by various reasons are always the core of vitiligo. Regulatory cell death (RCD) is an active and orderly death mode of cells regulated by genes, which widely exists in various life activities, plays a pivotal role in maintaining the homeostasis of the organism, and is closely related to the occurrence and development of many diseases. With the deepening of the research and understanding of RCD, people gradually found that there are many different forms of RCD in the lesions and perilesional skin of vitiligo patients, such as apoptosis, autophagy, pyroptosis, ferroptosis, and so on. Different cell death modes have different mechanisms in vitiligo, and different RCDs can interact and regulate each other. In this article, the mechanism related to RCD in the pathogenesis of vitiligo is reviewed, which provides new ideas for exploring the pathogenesis and targeted treatment of vitiligo.

Identifiants

pubmed: 38153369
doi: 10.1089/dna.2023.0188
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Lyu-Ye Liu (LY)

Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.

Si-Jia He (SJ)

Department of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, People's Republic of China.

Zhao Chen (Z)

First Clinical Medical College Shandong University of Traditional Chinese Medicine, Jinan, People's Republic of China.

Man Ge (M)

Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.

Chun-Yi Lyu (CY)

First Clinical Medical College Shandong University of Traditional Chinese Medicine, Jinan, People's Republic of China.

Dandan Gao (D)

Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.

Ji-Peng Yu (JP)

Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.

Meng-Han Cai (MH)

Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.

Jin-Xiang Yuan (JX)

Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.

Jun-Ling Zhang (JL)

Department of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, People's Republic of China.

Classifications MeSH